Replies to post #24240 on Marketgems Earnings Trader- Trading Strong or Weak (MKTGEMS)

[greenehugh]

Your welcome. Here is an informed opinion on Arcoxia posted by DewDiligence in reply to to my question.
>> Any thoughts on the probability of MRK's Arcoxia getting approval? <<
Clearly lower than it was a week ago. The FDA reviewers will now be asking themselves:
1. Do patients really need another Cox-2 inhibitor?
2. If the answer above is Yes, do patients need more than one new one?
3. If the answer above is No, should the addition be Merck’s Arcoxia or Novartis’ Prexige?

[bbgold]

MRK will be interesting
Might use a break above 35 to look for some Calls on it, but it could continue to trip into January. Interesting how the 3 year chart clearly showed the downtrend? Make sure and confirm any trades using a longer term chart, as I have seen them be very accurate lately :^)